InvestorLens

CVS — CVS HEALTH CORP

Health Care · Healthcare Plans

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying CVS?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
50
Institutional Conviction
Net distribution · 2 buying vs 2 selling last quarter
43
Macro Tailwind
Macro conditions are mixed for this sector
53
Congressional Activity
1 congressional purchase, 0 sales disclosed in the last 6 months
Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their CVS position last quarter, 2 bought and 2 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 1 congressional purchase, 0 sales disclosed in the last 6 months.

Supporting evidence
  • +2 tracked investors added or increased positions last quarter (Andreas Halvorsen, Steve Cohen)
  • +6 tracked investors reported holding CVS at their latest filing
Contradicting evidence — always shown
  • −2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About CVS HEALTH CORP (CVS)

CVS HEALTH CORP (CVS) appears in the most recent 13F filings of 6 tracked institutional investors. CVS HEALTH CORP is classified in the Health Care sector (Healthcare Plans industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1.1B. Across recent filings, tracked investors recorded 7 new positions, 13 increased, 14 reduced, and 3 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CVS

54
/100
Mixed Activity
Added / Increased20
Reduced14
Exited3
BearishBullish
Crowded Trade Score™

How many top investors track CVS

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

CVS Ownership Composition

How CVS HEALTH CORP is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
75% of tracked value
Institutions
6
tracked investors
Total Reported
$2B
combined 13F value
Types3
  • Multi-Strategy / Quant75.4%
  • Other18.8%
  • Macro5.8%
Multi-Strategy / Quant(3)
75.4%
Other(1)
18.8%
Macro(2)
5.8%

Tracked investors currently reporting CVS

1 tracked investor has since exited this position — listed separately below.

  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    10.3M
    Value
    $1.1B
    % Portfolio
    0.12%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    2.4M
    Value
    $246.5M
    % Portfolio
    0.09%
  • Andreas HalvorsenJun 30, 2026
    Viking Global Investors
    Shares
    3.7M
    Value
    $379M
    % Portfolio
    1.08%
  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    441K
    Value
    $45.6M
    % Portfolio
    0.19%
  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    2M
    Value
    $211.3M
    % Portfolio
    0.23%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    696.7K
    Value
    $72.1M
    % Portfolio
    0.10%

Previously held CVS

These investors reported CVS in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Daniel LoebThird Point LLC1.6M$99MSep 30, 2024

Recent activity

Frequently asked questions

How many institutional investors hold CVS?
6 tracked institutional investors disclosed a position in CVS (CVS HEALTH CORP) in their most recent 13F filing.
Who is the largest institutional holder of CVS?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in CVS, valued at $1.1B.
Did institutional ownership of CVS increase or decrease?
Across recent 13F filings, tracked investors recorded 7 new positions, 13 increased, 14 reduced, and 3 fully exited CVS.
What sector is CVS in?
CVS HEALTH CORP is classified in the Health Care GICS sector, Healthcare Plans industry.
Where does this CVS ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.